Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Early care of individuals at risk of developing chronic kidney disease (CKD) or in its initial stages is the most effective strategy to reduce morbidity and mortality. Renálida is a private healthcare institution specialized in renal health and CKD. It offers an Integrated Renal Health Program (IRHP) aimed at people with CKD or risk factors for developing it, combining clinical, educational, and psychosocial components in coordination with the treating physician. Most participants are older adults or people with disabilities affiliated with the National Institute of Social Services for Retirees and Pensioners (INSSJP–PAMI). The IRHP currently operates in a network with 259 referring physicians.
The primary objective is to evaluate the impact of the IRHP on treatment adherence and self-perceived quality of life among patients treated at Renálida between June 2024 and July 2025.
Analytical cross-sectional study with a convenience sample of patients referred by INSSJP–PAMI physicians, with CKD and/or risk factors who agreed to participate. Both newly enrolled patients (baseline group) and those with ≥4 months of follow-up were included. An anonymous self-administered questionnaire was applied, including sociodemographic variables, adherence to pharmacological and non-pharmacological treatment, and quality of life (EuroQol EQ-5D). Summary measures, 95% confidence intervals (95% CI), and chi-square tests (p<0.05) were calculated using R software.
A total of 901 patients responded: 48.4% (95% CI 45.1–51.1) were in the baseline group and 51.6% (95% CI 48.3–54.9) in follow-up. Mean age was 71.2 years (SD 9.7) with 52.5% (95% CI 47.7–57.3) women in the baseline group, and 71.4 years (SD 9.6) with 53.8% (95% CI 49.1–58.4) women in the follow-up group. Patients already in the IRHP reported adequate fluid intake (≥2 L/day) and greater adherence to dietary guidelines (p<0.05). The baseline group showed higher use of NSAIDs (non-steroidal anti-inflammatory drugs) (PR = 1.5), including use without medical prescription (PR = 1.6). This was significantly more frequent among women, both in the baseline (PR = 1.3) and follow-up groups (PR = 1.6). Higher levels of anxiety/depression were observed in the baseline group (p<0.05), whereas only in the follow-up group were these negative categories significantly more frequent among women than men (PR = 1.8). No significant differences were found for other variables. Quality of life was rated as good or excellent (score ≥7) by 62.3% (95% CI 57.6–66.9) of patients in the baseline group and 66.8% (95% CI 62.3–71.1) in the follow-up group (p>0.05).
Sustained participation in the IRHP is associated with improved self-care and adherence behaviors, reflecting the positive impact of an integrated, equitable, and sustainable renal care model. The reduction of inappropriate NSAID use and adherence to dietary recommendations represent meaningful improvements contributing to the prevention of kidney damage and disease progression. The finding of greater emotional distress among women reinforces the need to incorporate a gender-sensitive approach. These results highlight that renal health requires an integrated and interdisciplinary strategy, person-centered and based on equity and sustainability of care, to promote greater individual and collective empowerment in the prevention of kidney damage.
